Skip to content

Study for the treatment of depressive disorder by electroconvulsive therapy (ECT)

Study for the treatment of depressive disorder by electroconvulsive therapy (ECT)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060219
Enrollment
Unknown
Registered
2022-05-22
Start date
2022-05-11
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depressive disorder

Interventions

Electric convulsive therapy Group:electric convulsive therapy
Control group:None

Sponsors

Hefei Fourth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. According to the ICD-10 diagnostic criteria, inpatients with monophasic or bipolar depression, with or without psychotic symptoms; 2. Sign the informed consent form; 3. HAMD-17>16.

Exclusion criteria

Exclusion criteria: 1. Have participated in other relevant researchers within 30 days before enrollment; 2. Received ECT or rTMS treatment within 6 months before enrollment; 3. Have a history of abuse of psychoactive substances; 4. There are ECT related contraindications; 5. There are anesthetic risks such as cardiovascular disease; 6. Have a history of epilepsy; 7. The suicide risk rating before admission is high.

Design outcomes

Primary

MeasureTime frame
Hamilton depression Rating Scale, HAMD;Attention netwrk test;Continuous Performance Test,CPT;AMT;

Secondary

MeasureTime frame
DELIRIUM RATING SCALE-R-98 (DRS-R-98);CAM-CR;SIB;

Countries

China

Contacts

Public ContactXiaoming Kong

Hefei Fourth People's Hospital

kxm186@163.com+86 551 63616111

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026